Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear pore associated protein 1 pseudogene 6 (NPAP1P6) is classified as a human pseudogene, meaning it shares sequence similarity with the active Nuclear pore associated protein 1 (NPAP1) gene but does not encode a functional protein[7][5]. Like other pseudogenes, NPAP1P6 is believed to be non-functional in terms of protein-coding capacity, and there are currently no established biological or clinical functions tied to this locus. Pseudogenes may occasionally contribute to gene regulation via non-coding RNA mechanisms or act as microRNA decoys, but there is no documented evidence for such functions specifically for NPAP1P6[2][4][6]. NPAP1P6 is annotated in genomic databases as a member of the NPAP1 pseudogene family. Summary: NPAP1P6 should not be considered a drug target, biomarker, or functional protein-coding gene. Current evidence does not support it having functional biological or disease relevance[7][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear pore associated protein 1 pseudogene 6 (NPAP1P6).